Andrew McKibben
Investor Relations Contact at MIRUM PHARMACEUTICALS, INC.
Network origin in Andrew McKibben first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Andrew McKibben via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | General Counsel Chief Operating Officer Corporate Officer/Principal Director/Board Member | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Chairman | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| PRA HEALTH SCIENCES, INC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Medical Specialties | Chief Operating Officer | |
| DELCATH SYSTEMS, INC. | Medical Specialties | Director/Board Member | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Biotechnology | Chief Executive Officer | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chief Operating Officer Chief Executive Officer Corporate Officer/Principal | |
| ARATANA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Masters Business Admin | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
Council on International Educational Exchange, Inc.
 Council on International Educational Exchange, Inc. Miscellaneous Commercial ServicesCommercial Services Council on International Educational Exchange, Inc. provides educational services. The firm is a non-profit study abroad and intercultural exchange organization, transforms lives and builds bridges by promoting the exchange of ideas and experiences. It offers opportunities for cultural exchange, including work exchange programs, teach abroad programs, and a worldwide portfolio of study abroad and internship programs for college and high school students. The company was founded in 1947 and is headquartered in Portland, ME. | Miscellaneous Commercial Services | Chairman | |
Pacira Pharmaceuticals, Inc. (California)
 Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
| PANACOS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| Ohio University Foundation | Director/Board Member | ||
| Harvard Medical School | College/University | Graduate Degree | |
| RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member | |
| Red Rock Capital Management, Inc. | Corporate Officer/Principal | ||
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Cervantes Life Science Partners LLC | Corporate Officer/Principal | ||
| HLS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Flashlight Therapeutics, Inc.
 Flashlight Therapeutics, Inc. BiotechnologyHealth Technology Flashlight Therapeutics, Inc. develops therapeutics for unmet medical needs. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| EDGEWISE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
| T-Knife Therapeutics, Inc. | Director/Board Member |
Statistics
International
| United States | 47 |
| Canada | 3 |
| Ireland | 3 |
Sectoral
| Health Technology | 37 |
| Consumer Services | 6 |
| Commercial Services | 5 |
| Finance | 2 |
Operational
| Director/Board Member | 148 |
| Independent Dir/Board Member | 65 |
| Corporate Officer/Principal | 54 |
| President | 28 |
| Chief Executive Officer | 25 |
Most connected contacts
| Insiders | |
|---|---|
| Patrick Heron | 42 |
| Timothy Walbert | 40 |
| Michael Grey | 32 |
| Laura Brege | 27 |
| Laurent Fischer | 23 |
| Eric Bjerkholt | 21 |
| Sona Saira Ramasastry | 19 |
| William Fairey | 15 |
| Lon Cardon | 13 |
| Joanne Quan | 12 |
| Pamela Vig | 12 |
| Christopher Peetz | 11 |
| Paul K. Ross | 8 |
| Peter Radovich | 7 |
| Lara Krupka-Longpre | 7 |
- Stock Market
- Insiders
- Andrew McKibben
- Company connections
